Apple has moved beyond preliminary discussions with Chinese chipmaker ChangXin Memory Technologies and begun formal technical validation of the company’s DRAM chips.
The testing phase typically means a supplier is being considered for actual production use, not simply evaluated in theory.
DRAM contract prices climbed an estimated 55% to 60% in early 2026, driven largely by AI server demand pulling available memory supply away from consumer electronics.
Apple raised prices across most of its product lineup shortly after. Adding CXMT as a qualified supplier would give Apple a fourth source of memory to negotiate against Samsung, SK Hynix, and Micron, the three companies that currently dominate global DRAM supply.
Why Apple Is Moving Now
CXMT currently holds about 11% of global DRAM wafer capacity and is on track to reach 15% by 2028 as new facilities come online in Hefei, Shanghai, and Beijing.
Apple completing qualification now positions the company to tap that growing supply immediately once any political clearance arrives, rather than restarting the validation process later from the beginning.
Tim Cook has reportedly taken Apple’s case directly to the Trump administration, framing the arrangement as one where CXMT chips would supply devices built specifically for the Chinese market.
Under that structure, the existing allocation of chips from Samsung, SK Hynix, and Micron would stretch further across products sold in the United States and elsewhere.
The Political Obstacle Apple Is Trying to Remove
CXMT appears on the Pentagon’s list of companies linked to the Chinese military, but that designation primarily restricts Defense Department contracting and does not block commercial purchases by private companies.
Apple faces no legal barrier to buying CXMT chips today. What the company is actually lobbying for is a guarantee that CXMT will not be added to the Commerce Department’s Entity List, which carries a much harder restriction requiring U.S. companies to obtain an export license before any transaction.
Yangtze Memory Technologies, the other Chinese chipmaker Apple has discussed working with, already sits on that Entity List, which is why CXMT has become the more viable target.
A separate attempt to source memory from YMTC in 2022 collapsed after pushback from lawmakers, and Apple shelved those plans. Not everyone inside the current administration is said to support Apple’s renewed lobbying effort, leaving the outcome uncertain.
Apple has not committed to purchasing CXMT chips commercially. The company’s position, for now, is that it is running chips through technical validation while simultaneously working to secure political assurances that any future commercial relationship would not be disrupted by a last-minute regulatory change.
